Postchallenge plasma glucose and glycemic spikes are associated with pulse pressure in patients with impaired glucose tolerance and essential hypertension

Hypertension Research

Volumn 31, Issue 8, 2008, Pages 1565-1571

  Anan, Futoshi ^a,b   Masaki, Takayuki ^a   Eto, Takeshi ^b   Fukunaga, Naoya ^b   Iwao, Tetsu ^b   Kaneda, Koji ^b   Eshima, Nobuoki ^a   Saikawa, Tetsunori ^a   Yoshimatsu, Hironobu ^a  

^a OITA UNIVERSITY   (Japan)

^b OITA RED CROSS HOSPITAL   (Japan)

Author keywords

Essential hypertension; Impaired glucose tolerance; Left ventricular mass index; Post challenge glucose spikes; Pulse pressure

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE MASS; HEART RATE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; ORAL GLUCOSE TOLERANCE TEST; PULSE PRESSURE; SYSTOLIC BLOOD PRESSURE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 55449090286     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.1565     Document Type: Article

References (46)

1. Franklin SS, Gustin W 4th, Wong ND, et al: Hemodynamic patterns of age-related changes in blood pressure: the Framingham Heart Study. Circulation 1997; 96: 308-315.
2. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D: Is pulse pressure useful in predicting coronary heart disease? The Framingham Heart study. Circulation 1999; 100: 354-360.
3. Benetos A, Safar M, Rudnichi A, et al: Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension 1997; 30: 1410-1415.
4. Benetos A, Rudnichi A, Safar M, Guize L: Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension 1998; 32: 560-564.
5. Fang J, Madhavan S, Alderman MH: Pulse pressure: a predictor of cardiovascular mortality among normotensive subjects. Blood Pressure 2000; 9: 260-266.
6. Saloman V, Riley W, Kark JD, Nardo C, Folsom AR: Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes: the ARIC Study. Circulation 1995; 91: 1432-1443.
7. Schram MT, Henry RM, van Dijk RA, et al: Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes: the Hoorn Study. Hypertension 2004; 43: 176-181.
8. van Dijk RAJM, van Ittersum FJ, Westerhof N, et al: Determinants of brachial artery mean 24-h pulse pressure in individuals with type II diabetes mellitus and untreated mild hypertension. Clin Sci 2002; 102: 177-186.
9. Laakso M: Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 1999; 48: 937-942.
10. Lee JW, Lee DC, Im JA, Shim JY, Kim SM, Lee HR: Insulin resistance is associated with arterial stiffness independent of obesity in male adolescent. Hypertens Res 2007; 30: 5-11.
11. Barrett-Connor E, Ferrara A: Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. The Rancho Bernardo Study. Diabetes Care 1998; 21: 1236-1239.
12. DECODE Study Group: Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnosis criteria. Arch Intern Med 2001; 161: 397-404.
13. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A: Impaired glucose tolerance is a risk fator for cardiovascular disease, but not in impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 1999; 22: 920-924.
14. 1c level. Diabetes Care 2000; 23: 1830-1834.
15. Boyko EJ, Fujimoto WY, Leonetti DL, Newell-Morris L: Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care 2000; 23: 465-471.
16. Pickering TG, Ad Hoc Panel: Recommendations for the use of home (self) and ambulatory blood pressure monitoring. Am J Hypertens 1996; 9: 1-11.
17. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-1197.
18. Tochikubo O, Ikeda A, Miyajima E, Ishii M: Effect of insufficient sleep on blood pressure monitored by a new multibiomedical recorder. Hypertension 1996; 27: 1318-1324.
19. Kohara K, Nishida W, Maguchi M, Hiwada K: Autonomic nervous function in non-dipper essential hypertensive subjects. Evaluation by power spectral analysis of heart rate variability. Hypertension 1995; 26: 808-814.
20. Devereux RB, Alonso DR, Lutas EM, et al: Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458.
21. Uen S, Baulmann J, Dusing R, Glanzer K, Vetter H, Mengden T: ST-segment depression in hypertensive patients is linked to elevations in blood pressure, pulse pressure and double product by 24-h Cardiotens monitoring. J Hypertens 2003; 21: 977-983.
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
23. Kanauchi M, Motomiya K, Hashimoto T: Insulin secretion and sensitivity in non-obese and obese Japanese patients with coronary artery disease. Metabolism 2000; 51: 184-188.
24. Fukushima M, Usami M, Ikeda M, et al: Insulin secretion and insulin sensitivity at different stages of glucose tolerance: a cross-sectional study Japanese type 2 diabetes. Metabolism 2004; 53: 831-835.
25. Esposito K, Nappo F, Marfella R, et al: Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002; 106: 2067-2072.
26. Harris TB, Ferrucci L, Tracy RP, et al: Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999; 106: 506-512.
27. Ceriello A, Bortolotti N, Motz E, et al: Meal-generation oxidative stress in type 2 diabetic patients. Diabetes Care 1998; 21: 1529-1533.
28. Marfella R, Quagliaro L, Nappo F, Ceriello A, Giugliano D: Acute hyperglycemia induces an oxidant stress in healthy subjects. J Clin Invest 2001; 108: 635-636.
29. Ceriello A, Bortolotti N, Falleti E, et al: Total radical trapping antioxidant parameter in NIDDM patients. Diabetes Care 1997; 20: 194-197.
30. Tomiyama H, Kimura Y, Okazaki R, et al: Close relationship of abnormal glucose tolerance with endothelial dysfunction in hypertension. Hypertension 2000; 36: 245-249.
31. Kawano H, Motoyama T, Hirashima O, et al: Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 1999; 34: 146-154.
32. Heitzer T, Schling T, Krohn K, Meinertz T, Munzel T: Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001; 104: 2673-2678.
33. Haenni A, Andersson PE, Lind L, Berne C, Lithell H: Electrolyte changes and metabolic effects of lisinopril/bendrofluazide treatment. Results from a randomized, doubleblind study with parallel groups. Am J Hypertens 1994; 7: 615-622.
34. Risso A, Mercuri F, Quagliaro L, Damante G, Ceriello A: Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cell in culture. Am J Physiol 2001; 281: E924-E930.
35. Nakano S, Konishi K, Furuya K, et al: A prognostic role of mean 24-h pulse pressure level for cardiovascular events in type 2 diabetic subjects under 60 years of age. Diabetes Care 2005; 28: 102-107.
36. Tomiyama H, Yamada J, Koji Y, et al: Heart rate elevation precedes the development of metabolic syndrome in Japanese men: a prospective study. Hypertens Res 2007; 30: 417-426.
37. Anan F, Takahashi N, Ooie T, Yufu K, Saikawa T, Yoshimatsu H: Role of insulin resistance in nondipper essential hypertensive patients. Hypertens Res 2003; 26: 669-676.
38. Anan F, Yonemochi H, Masaki T, et al: High-densisty lipoprotein cholesterol and insulin resistance are independently and additive markers of left ventricular hypertrophy in essential hypertension. Hypertens Res 2007; 30: 125-131.
39. Facchini FS, Stoohs RA, Reaven GM: Enhanced sympathetic nervous system activity. Am J Hypertens 1995; 9: 1013-1017.
40. Khatter RS, Acharya DU, Kinsey C, Senoir R, Lahiri A: Longitudinal association of ambulatory pulse pressure with left ventricular mass and vascular hypertrophy in essential hypertension. J Hypertens 1997; 15: 737-743.
41. Jokiniitty JM, Majahalme SK, Kahonen MA, et al: Pulse pressure is the best predictor of future left ventricular mass and change in left ventricular mass: 10 years of follow up. J Hypertens 2001; 19: 2047-2054.
42. Tarazi RC: The role of the heart in hypertension. Clin Sci 1982; 63: 347S-365S.
43. Ceravolo R, Maio R, Pujia A, et al; Pulse pressure and endothelial dysfunction in never-treated hypertensive patients. J Am Coll Cardiol 2003; 41: 1753-1758.
44. Girerd X, Laurent S, Pannier B, Asmar R, Safar M: Arterial distensibility and left ventricular hypertrophy in patients with sustained essential hypertension. Am Heart J 1991; 122: 1210-1214.
45. Tanaka M, Babazono T, Takeda M, Iwamoto Y: Pulse pressure and chronic kidney disease in patients with type 2 diabtes. Hypertens Res 2006; 29: 345-352.
46. Takahashi N, Anan F, Nakagawa M, et al: Microalbuminuria, cardiovascular dysfunction, and insulin resistance in patients with type 2 diabetic patients. Metabolism 2004; 53: 1359-1364.